BHST · Bioharvest Sciences Inc.
$2.21
+0.17 (+8.33%)
At close · Jul 29
Market Cap
$49.76M
Shares
22.67M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.04
Open$2.09
Day$2.00–2.45
52W$1.82–12.80
Avg vol 30d45K
Short int72K · 0.3% float · 1.9d
Short vol17%
Last earningsAug 11, 2026
DataJan 2021–Jul 2026
Up next
Next earnings call
Aug 11, 2026
Scheduled
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−60%
below
Price vs 50-day avg
−34%
below
RSI (14)
23
oversold
MACD trend
Negative
52-week position
2%
near low
Momentum
relative strength
1-month return
−27%
trailing
6-month return
−57%
trailing
YTD return
−61%
this year
Relative strength
−64%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
4 of 20 funds reported for Jun 30 · net +85.9K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.32% of float · ▼ -0.1% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — mid 1-yr range
Squeeze score
30
low risk · 0–100
Fundamentals
Revenue growth
+37%
Y/Y
Free cash flow
$-9.6M
Balance sheet
$23.0M
net cash
Quant / Vol
risk profile
Volatility
75%
annualized · 1-yr
Max drawdown
−85%
past year
ATR
11.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Mar 31, 2026
Total CDMO revenue
· full year 2026
Initiated
$12M – $14M
prior FY $34.51M
midpoint −62.3% Y/Y
D2C revenue
· full year 2026
Initiated
$38M – $42M
prior FY $34.51M
midpoint +15.9% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−60%
Bearish
Price vs 50-day avg
−34%
Bearish
RSI (14)
23
Neutral
MACD trend
Negative
Bearish
52-week position
2%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $3 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
4 of 20 funds reported for Jun 30 · net +85.9K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.32% of float · ▼ -0.1% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $2
Now $2 · 2%
52-wk high $13
vs 200-day avg -60%
vs 50-day avg -34%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Packaged Foods — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BHST
this stock
Bioharvest Sciences Inc.
|
$49.76M | -60.7% | +37.0% | — | 0.3% |
|
JBS
Jbs N.V.
|
$45.82B | -3.4% | — | — | 1.0% |
|
KHC
Kraft Heinz Co
|
$32.37B | +14.5% | +0.6% | — | 7.8% |
|
GIS
General Mills Inc
|
$20.09B | -17.9% | +4.1% | — | 10.2% |
|
HRL
Hormel Foods Corp /De/
|
$14.07B | +9.2% | -2.8% | 30.1 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BHST | -10.5% | -26.9% | -57.1% | -28.7% | -60.7% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | -9.5% | -26.9% | -64.5% | -27.9% | -69.3% |